Omega Diagnostics Group PLC products

Rapid diagnostic test for visual detection of SARS-CoV-2 antigen. VISITECT® COVID-19 Antigen is a qualitative lateral flow immunoassay for the detection of SARS-CoV-2 nucleocapsid protein (antigen) in respiratory specimens (throat and nasal swab, or nasal only).

Rapid diagnostic test for visual detection of three antibody isotypes to SARS-CoV-2. VISITECT® COVID-19 IgM/IgA/IgG is a qualitative rapid diagnostic test for the separate detection of IgM, IgA and IgG antibodies specific to SARS-CoV-2. The manual lateral flow immunoassay is for professional use only and is not to be used for self-testing.

ELISA for the detection of IgG antibodies to SARS-CoV-2 in human serum or plasma.

VISITECT CD4 in-vitro diagnostic test is for use as an aid in the management of patients with pre-diagnosed HIV infection. This visually read test is designed to be used at the point-of-care and therefore has utility in decentralised diagnostic settings. The VISITECT® CD4 Rapid Test is a semi-quantitative assay for the estimation of CD4 protein on the surface of CD4+ T cells in human whole blood to indicate whether the level is above or below 350 cells/ µL within pre-diagnosed HIV patients.

VISITECT® CD4 Advanced Disease supports the identification of advanced disease in people living with HIV. VISITECT® CD4 Advanced Disease is a unique, instrument-free, rapid and disposable CD4 test benefiting patients and healthcare providers.